Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 135

1.

No benefit of a dual coil over a single coil ICD lead: evidence from the Sudden Cardiac Death in Heart Failure Trial.

Aoukar PS, Poole JE, Johnson GW, Anderson J, Hellkamp AS, Mark DB, Lee KL, Bardy GH.

Heart Rhythm. 2013 Jul;10(7):970-6. doi: 10.1016/j.hrthm.2013.03.046. Epub 2013 Apr 4.

PMID:
23562699
2.

Rapid-rate nonsustained ventricular tachycardia found on implantable cardioverter-defibrillator interrogation: relationship to outcomes in the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial).

Chen J, Johnson G, Hellkamp AS, Anderson J, Mark DB, Lee KL, Bardy GH, Poole JE.

J Am Coll Cardiol. 2013 May 28;61(21):2161-8. doi: 10.1016/j.jacc.2013.02.046. Epub 2013 Mar 26.

3.

SCD-HeFT: Use of R-R interval statistics for long-term risk stratification for arrhythmic sudden cardiac death.

Au-Yeung WT, Reinhall PG, Poole JE, Anderson J, Johnson G, Fletcher RD, Moore HJ, Mark DB, Lee KL, Bardy GH.

Heart Rhythm. 2015 Oct;12(10):2058-66. doi: 10.1016/j.hrthm.2015.06.030. Epub 2015 Jun 19. Erratum in: Heart Rhythm. 2015 Dec;12(12):2520.

4.

Single-coil and dual-coil defibrillator leads and association with clinical outcomes in a complete Danish nationwide ICD cohort.

Larsen JM, Hjortshøj SP, Nielsen JC, Johansen JB, Petersen HH, Haarbo J, Johansen MB, Thøgersen AM.

Heart Rhythm. 2016 Mar;13(3):706-12. doi: 10.1016/j.hrthm.2015.11.034. Epub 2015 Nov 22.

PMID:
26593333
5.

No benefit from defibrillation threshold testing in the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial).

Blatt JA, Poole JE, Johnson GW, Callans DJ, Raitt MH, Reddy RK, Marchlinski FE, Yee R, Guarnieri T, Talajic M, Wilber DJ, Anderson J, Chung K, Wong WS, Mark DB, Lee KL, Bardy GH; SCD-HeFT Investigators..

J Am Coll Cardiol. 2008 Aug 12;52(7):551-6. doi: 10.1016/j.jacc.2008.04.051.

6.

Use of the 6-min walk distance to identify variations in treatment benefits from implantable cardioverter-defibrillator and amiodarone: results from the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial).

Fishbein DP, Hellkamp AS, Mark DB, Walsh MN, Poole JE, Anderson J, Johnson G, Lee KL, Bardy GH; SCD-HeFT Investigators..

J Am Coll Cardiol. 2014 Jun 17;63(23):2560-8. doi: 10.1016/j.jacc.2014.02.602. Epub 2014 Apr 9.

7.

Implantable intravascular defibrillator: defibrillation thresholds of an intravascular cardioverter-defibrillator compared with those of a conventional ICD in humans.

Neuzil P, Reddy VY, Merkely B, Geller L, Molnar L, Bednarek J, Bartus K, Richey M, Bsee TJ, Sanders WE Jr.

Heart Rhythm. 2014 Feb;11(2):210-5. doi: 10.1016/j.hrthm.2013.10.035. Epub 2013 Oct 18.

PMID:
24144885
8.

Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the sudden cardiac death in heart failure trial.

Packer DL, Prutkin JM, Hellkamp AS, Mitchell LB, Bernstein RC, Wood F, Boehmer JP, Carlson MD, Frantz RP, McNulty SE, Rogers JG, Anderson J, Johnson GW, Walsh MN, Poole JE, Mark DB, Lee KL, Bardy GH.

Circulation. 2009 Dec 1;120(22):2170-6. doi: 10.1161/CIRCULATIONAHA.109.853689. Epub 2009 Nov 16. Erratum in: Circulation. 2010 Feb 16;121(6):e39.

9.

Clinical impact, safety, and efficacy of single- versus dual-coil ICD leads in MADIT-CRT.

Kutyifa V, Huth Ruwald AC, Aktas MK, Jons C, McNitt S, Polonsky B, Geller L, Merkely B, Moss AJ, Zareba W, Bloch Thomsen PE.

J Cardiovasc Electrophysiol. 2013 Nov;24(11):1246-52. doi: 10.1111/jce.12219. Epub 2013 Jul 25.

PMID:
23889863
10.

Utilization trends and clinical outcomes in patients implanted with a single- vs a dual-coil implantable cardioverter-defibrillator lead: Insights from the ALTITUDE Study.

Hsu JC, Saxon LA, Jones PW, Wehrenberg S, Marcus GM.

Heart Rhythm. 2015 Aug;12(8):1770-5. doi: 10.1016/j.hrthm.2015.04.030. Epub 2015 Apr 24.

PMID:
25916569
11.

Determinants of patient survival rate after implantation of a cardioverter-defibrillator without resynchronisation capability.

Lelakowski J, Piekarz J, Rydlewska A, Majewski J, Senderek T, Ząbek A, Małecka B.

Kardiol Pol. 2012;70(11):1099-110.

12.

Failure rates of single- versus dual-coil nonrecalled sprint quattro defibrillator leads.

Shariff N, Alluri K, Saba S.

Am J Cardiol. 2015 Jan 15;115(2):202-5. doi: 10.1016/j.amjcard.2014.10.025. Epub 2014 Oct 30.

PMID:
25465935
13.

Comparison of defibrillation efficacy using implantable cardioverter-defibrillator with single- or dual-coil defibrillation leads and active can.

Lubiński A, Lewicka-Nowak E, Zienciuk A, Królak T, Kempa M, Pazdyga A, Raczak G, Swiatecka G.

Kardiol Pol. 2005 Sep;63(3):234-41; discussion 242-3.

PMID:
16180177
14.

Clinical predictors of atrial defibrillation thresholds with a dual-coil, active pectoral lead system.

Rashba EJ, Shorofsky SR, Brown T, Peters RW, Gold MR.

Heart Rhythm. 2005 Jan;2(1):49-54.

PMID:
15851265
15.

Multicentre comparison Of shock efficacy using single-vs. Dual-coil lead systems and Anodal vs. cathodaL polarITY defibrillation in patients undergoing transvenous cardioverter-defibrillator implantation. The MODALITY study.

Baccillieri MS, Gasparini G, Benacchio L, Zorzi A, Marras E, Zerbo F, Tomasi L, Vaccari D, Pastore G, Bonanno C, Molon G, Zanotto G, Fusco A, Carasi M, Zorzi A, Calzolari V, Ignatiuk B, Cannas S, Vaglio A, Al Bunni M, Pedrini A, Olivieri A, Rampazzo R, Minicuci N, Corrado D, Verlato R.

J Interv Card Electrophysiol. 2015 Jun;43(1):45-54. doi: 10.1007/s10840-015-9980-9. Epub 2015 Feb 19.

PMID:
25690336
16.

Effect of defibrillation threshold testing on heart failure hospitalization or death in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT).

Aktas MK, Huang DT, Daubert JP, Schuger CD, McNitt S, Goldenberg I, Moss AJ, Zareba W.

Heart Rhythm. 2013 Feb;10(2):193-9. doi: 10.1016/j.hrthm.2012.10.024. Epub 2012 Oct 18.

PMID:
23085128
17.

Outcomes in African Americans undergoing cardioverter-defibrillator implantation for primary prevention of sudden cardiac death: findings from the Prospective Observational Study of Implantable Cardioverter-Defibrillators (PROSE-ICD).

Zhang Y, Kennedy R, Blasco-Colmenares E, Butcher B, Norgard S, Eldadah Z, Dickfeld T, Ellenbogen KA, Marine JE, Guallar E, Tomaselli GF, Cheng A.

Heart Rhythm. 2014 Aug;11(8):1377-83. doi: 10.1016/j.hrthm.2014.04.039. Epub 2014 May 2.

18.

Prospective, randomized comparison in humans of a unipolar defibrillation system with that using an additional superior vena cava electrode.

Bardy GH, Dolack GL, Kudenchuk PJ, Poole JE, Mehra R, Johnson G.

Circulation. 1994 Mar;89(3):1090-3.

PMID:
8124794
19.

Effect of an active abdominal pulse generator on defibrillation thresholds with a dual-coil, transvenous ICD lead system.

Rashba EJ, Farasat M, Kirk MM, Shorofsky SR, Peters RW, Gold MR.

J Cardiovasc Electrophysiol. 2006 Jun;17(6):617-20.

PMID:
16836709
20.

Cost-effectiveness of defibrillator therapy or amiodarone in chronic stable heart failure: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).

Mark DB, Nelson CL, Anstrom KJ, Al-Khatib SM, Tsiatis AA, Cowper PA, Clapp-Channing NE, Davidson-Ray L, Poole JE, Johnson G, Anderson J, Lee KL, Bardy GH; SCD-HeFT Investigators..

Circulation. 2006 Jul 11;114(2):135-42. Epub 2006 Jul 3.

Supplemental Content

Support Center